A truncated pre-F protein mRNA vaccine elicits an enhanced immune response and protection against respiratory syncytial virus
Min Lin,
Yifan Yin,
Xiaomeng Zhao,
Chen Wang,
Xueqing Zhu,
Letao Zhan,
Li Chen,
Siling Wang,
Xue Lin,
Jun Zhang (zhangj@xmu.edu.cn),
Ningshao Xia (nsxia@xmu.edu.cn) and
Zizheng Zheng (zhengzizheng@xmu.edu.cn)
Additional contact information
Min Lin: Xiamen University
Yifan Yin: Xiamen University
Xiaomeng Zhao: Xiamen University
Chen Wang: Xiamen University
Xueqing Zhu: Xiamen University
Letao Zhan: Xiamen University
Li Chen: Xiamen University
Siling Wang: Xiamen University
Xue Lin: Xiamen University
Jun Zhang: Xiamen University
Ningshao Xia: Xiamen University
Zizheng Zheng: Xiamen University
Nature Communications, 2025, vol. 16, issue 1, 1-17
Abstract:
Abstract The Food and Drug Administration (FDA) has approved vaccines designed by GSK, Pfizer and Moderna to protect high-risk populations against respiratory syncytial virus (RSV). These vaccines employ the pre-fusion F (pre-F) protein as the immunogen. In this study, we explored an mRNA vaccine based on a modified pre-F protein called LC2DM-lipid nanoparticle (LC2DM-LNP). This vaccine features a truncated version of the pre-F protein that is anchored to the cell membrane. Our experiments in young and old female mice revealed that the LC2DM-LNP vaccine elicited robust neutralizing antibody titers. Moreover, LC2DM-LNP prompted a Th1-skewed T-cell immune response in female rodent models. Female cotton rats immunized with LC2DM-LNP demonstrated strong immunity to RSV, without signs of vaccine-enhanced respiratory disease (VERD), even in cases of breakthrough infection. Importantly, when administered to pregnant female cotton rats, LC2DM-LNP ensured the transfer of pre-F-specific antibodies to the offspring and provided protection against RSV without increasing lung inflammation. Our findings suggest that LC2DM-LNP could serve as an alternative RSV vaccine candidate for high-risk groups.
Date: 2025
References: View references in EconPapers View complete reference list from CitEc
Citations:
Downloads: (external link)
https://www.nature.com/articles/s41467-025-56302-1 Abstract (text/html)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-56302-1
Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/
DOI: 10.1038/s41467-025-56302-1
Access Statistics for this article
Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie
More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla (sonal.shukla@springer.com) and Springer Nature Abstracting and Indexing (indexing@springernature.com).